The FDA sent out updates during the week ending April 7 regarding drugs that are currently in shortage:
- Cefotetan Disodium Injection (Updated – Currently in Shortage)
- L-Cysteine Hydrochloride Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Methylprednisolone Sodium Succinate for Injection, USP (Updated – Currently in Shortage)
- Nitrous Oxide, Gas (Updated – Currently in Shortage)
- Penicillin G Benzathine (Bicillin L-A) Injection (Updated – Currently in Shortage)
- Penicillin G Benzathine and Penicillin G Procaine (Bicillin C-R) Injection (Updated – Currently in Shortage)
- Penicillin G Procaine Injection (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Scopolamine (Transderm Scop) Transdermal System Patch (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
(Source: U.S. Food & Drug Adminstration)
